FDA grants breakthrough device designation to Natera's cancer detection test
Go back to FDA grants breakthrough device designation to Natera's cancer detection test| (NASDAQ: NTRA) | Delayed: 413.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $413.38 | 52 Week High | $13.80 | |||
| Open | $413.38 | 52 Week Low | $6.52 | |||
| Day High | $413.38 | P/E | N/A | |||
| Day Low | $413.38 | EPS | $0.00 | |||
| Volume | 2,966 | |||||



